# Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass

> **NCT00747331** · PHASE4 · COMPLETED · sponsor: **IRCCS Policlinico S. Donato** · enrollment: 80 (estimated)

## Conditions studied

- Cardiac Complications
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** Fenoldopam mesilate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00747331
- **Lead sponsor:** IRCCS Policlinico S. Donato
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2009-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00747331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00747331, "Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00747331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*